Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs Lemonade Inc (LMND) Price & Performance

iShares JPMorgan USD Emerging Markets Bond ETFTrade
Lemonade IncTrade

Price performance (Past 24H)

Key statistics

iShares JPMorgan USD Emerging Markets Bond ETF vs Lemonade Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.63, while Lemonade Inc trades at $64.25 (market cap $5.07B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals.

EMBLMND
Sector
Fixed IncomeFinancials
52-Week High
$97.74$96.57
52-Week Low
$91.59$36.28
Market Cap
$5.07B
Enterprise Value
$4.90B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares JPMorgan USD Emerging Markets Bond ETF

EMB trades at $95.54, down slightly by 0.03% on the day, with a bearish technical signal driven by moving averages. Recent corporate actions include scheduled dividends for 2026, with payouts of $0.41 and $0.40 per share. News highlights focus on emerging market bond risks and Federal Reserve policy impacts, with the ETF showing a 12% total return over the past year but only 1% year-to-date gains as of May 2026.

The outlook for EMB is cautious due to bearish technical indicators and macroeconomic sensitivities. Key risks include emerging market sovereign default exposure and interest rate volatility. Analyst sentiment is mixed, with attention on Fed policy and global bond market dynamics as critical drivers for future performance.

Lemonade Inc

Lemonade (LMND) trades at $64.675, down 7.79% over the past day, reflecting recent volatility. The stock shows a bullish technical signal with moving averages supporting upward momentum, while oscillators remain neutral. Fundamentally, revenue growth is robust, increasing from $257M in 2022 to $738M in 2025, but net losses persist, with a net income margin of -22.43% in 2025. Recent news highlights expansion into new states and reinsurance program improvements, driving investor interest despite profitability challenges.

The outlook for LMND is mixed; growth opportunities from AI-driven insurance expansion and state rollouts offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $69.60 price target, indicating limited near-term upside. Investors should weigh strong revenue trends against the path to profitability, with positive cash flow projected by 2026 being a key monitorable.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares JPMorgan USD Emerging Markets Bond ETF

EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.

Read more on EMB

About Lemonade Inc

Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.

Read more on LMND